Thurston Gavin
Regeneron Pharmaceuticals Inc, Tarrytown, NY 10591, USA.
J Anat. 2002 Jun;200(6):575-80. doi: 10.1046/j.1469-7580.2002.00061.x.
Vascular endothelial growth factor (VEGF) and Angiopoietins are families of vascular-specific growth factors that regulate blood vessel growth, maturation and function. To learn more about the effects of these factors in vivo, we have overexpressed VEGF-A or Angiopoietin-1 (Ang1) in two systems in mice, and examined the effects on blood vessel growth and function. In one set of studies, VEGF, Ang1, or both factors, were transgenically overexpressed in the skin under the keratin-14 (K14) promoter. The skin of mice overexpressing VEGF (K14-VEGF) had numerous tortuous, capillary-sized vessels which were leaky to the plasma tracer Evans blue under baseline conditions. In contrast, the skin of mice overexpressing Ang1 (K14-Ang1) had enlarged dermal vessels without a significant increase in vessel number. These enlarged vessels were less leaky than those of wild-type mice in response to inflammatory stimuli. In double transgenic mice overexpressing VEGF and Ang1, the size and number of skin vessels were both increased; however, the vessels were not leaky. In a second set of studies, VEGF or Ang1 was systemically delivered using an adenoviral approach. Intravenous injection of adenovirus encoding VEGF (Adeno-VEGF) resulted in widespread tissue oedema within 1-2 days after administration, whereas injection of Adeno-Ang1 resulted in the skin vessels becoming less leaky in response to topical inflammatory stimuli or local injection of VEGF. The decreased leakage was not accompanied by morphological changes. Thus, overexpressing VEGF appears to promote growth of new vessels accompanied by plasma leakage, whereas overexpressing Ang1 promotes the enlargement of existing vessels and a resistance to leakage. Further understanding of the interrelationship of these factors during normal development could lead to their application in the treatment of ischaemic diseases.
血管内皮生长因子(VEGF)和血管生成素是血管特异性生长因子家族,可调节血管生长、成熟和功能。为了更深入了解这些因子在体内的作用,我们在小鼠的两种系统中过表达了VEGF-A或血管生成素-1(Ang1),并研究了其对血管生长和功能的影响。在一组研究中,VEGF、Ang1或这两种因子在角蛋白-14(K14)启动子的调控下在皮肤中转基因过表达。过表达VEGF的小鼠(K14-VEGF)皮肤中有许多蜿蜒曲折的毛细血管大小的血管,在基线条件下对血浆示踪剂伊文思蓝有渗漏。相比之下,过表达Ang1的小鼠(K14-Ang1)皮肤中的真皮血管增大,但血管数量没有显著增加。这些增大的血管在受到炎症刺激时比野生型小鼠的血管渗漏更少。在过表达VEGF和Ang1的双转基因小鼠中,皮肤血管的大小和数量均增加;然而,这些血管没有渗漏。在第二组研究中,使用腺病毒方法全身递送VEGF或Ang1。静脉注射编码VEGF的腺病毒(腺病毒-VEGF)在给药后1-2天内导致广泛的组织水肿,而注射腺病毒-Ang1导致皮肤血管在受到局部炎症刺激或局部注射VEGF时渗漏减少。渗漏减少并未伴有形态学改变。因此,过表达VEGF似乎促进新血管生长并伴有血浆渗漏,而过表达Ang1则促进现有血管增大并抵抗渗漏。进一步了解这些因子在正常发育过程中的相互关系可能会使其应用于缺血性疾病的治疗。